Loading…
Loading…
See exactly how IAK's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IAK and 80,000+ other tickers.
This ETF, known as the iShares U.S. Insurance ETF, is designed to replicate the investment performance of a specific underlying index. This benchmark consists exclusively of shares from American companies that operate within the insurance industry.
iShares U.S. Insurance ETF (IAK) earns a Very Attractive rating for its superior allocation to profitable, undervalued insurance stocks. IAK's holdings deliver an 18% ROIC, 4% FCF yield, and a low 0.8 PEBV ratio, outperforming SPY and XLF on key profitability and valuation metrics. IAK benefits from strong, recurring macro demand drivers in the insurance industry, including regulatory requirements and embedded coverage in U.S. commerce.
iShares U.S. Insurance ETF offers focused, cap-weighted exposure to the U.S. insurance sector, with a strong P&C tilt. IAK benefits from a hawkish Fed, subdued catastrophe risk, and active M&A, supporting sector profitability and potential multiple expansion. The ETF trades at attractive valuations—P/E of 11.7x, P/B of 1.66x—relative to the S&P 500, with a low beta profile.
Tech capex and geopolitics have dominated the headlines this year, but opportunities emerge elsewhere. Dividend growth investing could be hitting its stride amid shifting macro and micro trends. Novel, forward-looking strategies may help asset allocators find alpha beyond traditional income approaches.
If you're interested in broad exposure to the Financials - Insurance segment of the equity market, look no further than the iShares U.S. Insurance ETF (IAK), a passively managed exchange traded fund launched on May 1, 2006.
iShares U.S. Insurance ETF (NYSEARCA:IAK - Get Free Report) saw a significant growth in short interest in March. As of March 13th, there was short interest totaling 61,579 shares, a growth of 140.9% from the February 26th total of 25,565 shares. Approximately 1.9% of the company's stock are short sold. Based on an average daily